Research Dx is pleased to announce two new additions to the senior management team. Stephen Jones as Chief Operating Officer and Tom Li as VP Business Development.
Stephen Jones
Chief Operating Officer
Steve Jones is the COO for ResearchDx responsible for end-to-end oversight of all functions including laboratory operations, business development and research and development. Prior to this role Steve has worked for several large companies based in the Healthcare or Research fields. Experience includes extensive involvement in the high complexity Reference Lab space with terms at LabCorp and Clarient. Commercial experience includes leadership roles at Roche, Biocare Medical, GE and Invicro.
With over 40 years experience in Pathology and a LEAN Six Sigma Qualification from GE Steve moved to the US in 2002 from England. With a consistent focus on quality and building customer relationships Steve has been central to the growth of several outsourced service businesses.
Steve has a Masters in Biomedical Sciences from Nottingham University in the UK and has been involved in numerous national and international quality assurance schemes. Living in Southern California with his wife and cat, Steve enjoys his spare time, traveling, mountain biking, flying radio control airplanes and ocean kayaking. Currently studying to gain his private glider pilot certification.
Steve believes in being open and honest in all transactions, feeling that whilst trust and respect are hard to gain, they are easy to lose.
Tom Li
VP Business Development
Tom Li is the Vice President of Business Development at Research Dx and leads the company’s efforts to develop and cultivate business relationships with existing and prospective partners. Prior to this role, Tom has held leadership positions at various CRO, diagnostic companies, and research institutes including Thermofisher Scientific, Genscript, Burning Rock Dx and Innostar.
Tom received his BS in biology from UCSD and is passionate about precision medicine and its promise to deliver personalized, revolutionary, new therapeutics that improve patient outcomes and give clinicians better tools to make informed decisions on treatment options.
He has lived in Shanghai, Southern California, and Toronto over the years and enjoys traveling, hiking, snow sports and target shooting. Tom believes that the foundation of successful business relationships is built around communication, trust, and win-win cooperation that brings value to all parties.
About Research Dx
ResearchDx is a full-service diagnostic development organization, providing a ‘start-finish’ partnership for the co-development of companion diagnostics. At RDx, we design, manage, de-risk and coordinate every aspect of the diagnostics development process, from biomarker discovery, assay design and validation, clinical trial management and logistics, and regulatory submission. As a uniquely technology and platform agnostic solutions provider, we look at all available options to best support your project.
As your single CLIA, CAP and ISO13485 certified partner, we understand the challenges of CDx development and strive to provide a cost effective, de-risked path and clear strategic guidance. RDx provides a flexible process that is agile and adaptable and we dedicate ourselves to the success of our partners.